| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 15, 2026 | Option exercise(M) | 3K | $12.65 | $38K | 7K |
| May 15, 2026 | Sell(S) | 3K | $18.76 | $56K | 4K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 15, 2026 | Option exercise(M) | 3K | — | $0 | 129K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001918845-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Avalo Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.